India's Natco Pharma rises on Q3 profit surge
** Shares of Natco Pharma NATP.NS up 4.1% at 891.65
rupees, their highest since Sept. 2023
** Drug maker reported a more than three-fold jump in
Dec-qtr consol net profit
** Stock top pct gainer on Nifty pharma index .NIPHARM
which is down 1.2%
** Avg rating of analysts on NATP at "hold;" median PT is
795 rupees - LSEG data
** Stock up ~45% in 2023 after falling for two straight
years
(Reporting by Kashish Tandon in Bengaluru)
((kashish.tandon@thomsonreuters.com))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees